{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T07:56:25Z","timestamp":1715586985371},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T00:00:00Z","timestamp":1395446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-013-1040-7","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T12:15:20Z","timestamp":1395404120000},"source":"Crossref","is-referenced-by-count":3,"title":["Switching from clopidogrel to prasugrel in patients having coronary stent implantation"],"prefix":"10.1007","author":[{"given":"Guido","family":"Parodi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Bellandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Comito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazario","family":"Carrabba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. N. Erica","family":"Ramazzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Franco","family":"Gensini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Antoniucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,22]]},"reference":[{"key":"1040_CR1","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","volume":"116","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Trenk D, Frelinger AL, PRINCIPLE-TIMI 44 Investigators et al (2007) Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial. Circulation 116:2923\u20132932","journal-title":"Circulation"},{"key":"1040_CR2","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1161\/CIRCULATIONAHA.104.502815","volume":"111","author":"SD Wiviott","year":"2005","unstructured":"Wiviott SD, Antman EM, Winters KJ, JUMBO-TIMI 26 Investigators et al (2005) Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the joint utilization of medications to block platelets optimally (JUMBO)-TIMI 26 trial. Circulation 111:3366\u20133373","journal-title":"Circulation"},{"key":"1040_CR3","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH (2007) TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"1040_CR4","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","volume":"31","author":"W Wijns","year":"2010","unstructured":"Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501\u20132555","journal-title":"Eur Heart J"},{"key":"1040_CR5","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/CIR.0b013e31823a5596","volume":"124","author":"GN Levine","year":"2011","unstructured":"Levine GN, Bates ER, Blankenship JC, ACCF, AHA, SCAI Practice Guidelines et al (2011) ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: executive summary (2011). A report of the American college of cardiology foundation\/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation 124:2574\u20132609","journal-title":"Circulation"},{"key":"1040_CR6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"SD Wiviott","year":"2008","unstructured":"Wiviott SD, Braunwald E, Angiolillo DJ, TRITON-TIMI 38 investigators et al (2008) Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38. Circulation 118:1626\u20131636","journal-title":"Circulation"},{"key":"1040_CR7","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/eurheartj\/ehn362","volume":"29","author":"SA Murphy","year":"2008","unstructured":"Murphy SA, Antman EM, Wiviott SD et al (2008) Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial. Eur Heart J 29:2473\u20132479","journal-title":"Eur Heart J"},{"key":"1040_CR8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","volume":"371","author":"SD Wiviott","year":"2008","unstructured":"Wiviott SD, Braunwald E, McCabe CH, TRITON-TIMI 38 investigators et al (2008) Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 371:1353\u20131363","journal-title":"Lancet"},{"key":"1040_CR9","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/CIRCULATIONAHA.109.883454","volume":"120","author":"A Migliorini","year":"2009","unstructured":"Migliorini A, Valenti R, Marcucci R et al (2009) High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease. Circulation 120:2214\u20132221","journal-title":"Circulation"},{"key":"1040_CR10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.amjcard.2011.08.034","volume":"109","author":"G Parodi","year":"2012","unstructured":"Parodi G, Bellandi B, Venditti F et al (2012) Residual platelet reactivity, bleedings and adherence to treatment in patients having coronary stent implantation treated with prasugrel. Am J Cardiol 109:214\u2013218","journal-title":"Am J Cardiol"},{"key":"1040_CR11","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","volume":"306","author":"G Parodi","year":"2011","unstructured":"Parodi G, Marcucci R, Valenti R et al (2011) Association between high residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing percutaneous coronary intervention. JAMA 306:1215\u20131223","journal-title":"JAMA"},{"key":"1040_CR12","first-page":"2161","volume":"1097","author":"D Erlinge","year":"2013","unstructured":"Erlinge D, Gurbel PA, James S et al (2013) Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: the generations trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients. J Am Coll Cardiol 1097:2161\u20132162","journal-title":"J Am Coll Cardiol"},{"key":"1040_CR13","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.jacc.2012.08.964","volume":"60","author":"D Erlinge","year":"2012","unstructured":"Erlinge D, Ten Berg J, Foley D et al (2012) Reduction in platelet reactivity with prasugrel 5\u00a0mg in low-body-weight patients is noninferior to prasugrel 10\u00a0mg in higher-body-weight patients: results from the feather trial. J Am Coll Cardiol 60:2032\u20132040","journal-title":"J Am Coll Cardiol"},{"key":"1040_CR14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","volume":"31","author":"The TIMI study group","year":"1985","unstructured":"The TIMI study group (1985) The thrombolysis in myocardial infarction trial. N Engl J Med 31:932\u2013936","journal-title":"N Engl J Med"},{"key":"1040_CR15","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials. A consensus report from the bleeding academic research consortium. Circulation 123:2736\u20132747","journal-title":"Circulation"},{"key":"1040_CR16","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","volume":"367","author":"MT Roe","year":"2012","unstructured":"Roe MT, Armstrong PW, Fox KA, TRILOGY ACS Investigators et al (2012) Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. New Engl J Med 367:1297\u20131309","journal-title":"New Engl J Med"},{"key":"1040_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0091270008315310","volume":"48","author":"DS Small","year":"2008","unstructured":"Small DS, Farid NA, Payne CD et al (2008) Effects of proton pump inhibitors lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol 48:475\u2013484","journal-title":"J Clin Pharmacol"},{"key":"1040_CR18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ccd.24480","volume":"81","author":"S Azmoon","year":"2012","unstructured":"Azmoon S, Angiolillo D (2012) Switching antiplatelets regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI. Cath Cardiovasc Interv 81:232\u2013242","journal-title":"Cath Cardiovasc Interv"},{"issue":"66","key":"1040_CR19","first-page":"9","volume":"153","author":"JT Brandt","year":"2007","unstructured":"Brandt JT, Payne CD, Wiviott SD et al (2007) A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 153(66):9\u201316","journal-title":"Am Heart J"},{"key":"1040_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/09537100801891640","volume":"19","author":"CD Payne","year":"2008","unstructured":"Payne CD, Li YG, Brandt JT et al (2008) Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects. Platelets 19:275\u2013281","journal-title":"Platelets"},{"key":"1040_CR21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2010.02.072","volume":"56","author":"DJ Angiolillo","year":"2010","unstructured":"Angiolillo DJ, Saucedo JF, Deraad R, SWAP Investigators et al (2010) Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study. J Am Coll Cardiol 56:1017\u20131023","journal-title":"J Am Coll Cardiol"},{"key":"1040_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH09-07-0482","volume":"103","author":"G Montalescot","year":"2010","unstructured":"Montalescot G, Sideris G, Cohen R et al (2010) Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study. Thromb Haemost 103:213\u2013223","journal-title":"Thromb Haemost"},{"key":"1040_CR23","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1016\/j.cjca.2012.07.655","volume":"28","author":"JD Diodati","year":"2012","unstructured":"Diodati JD, Fung A, Saucedo JF et al (2012) Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: the TRIPLET trial. Can J Cardiol 28:S377 724 Abstract","journal-title":"Can J Cardiol"},{"key":"1040_CR24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.amjcard.2012.11.058","volume":"111","author":"JP Loh","year":"2013","unstructured":"Loh JP, Pendyala LK, Kitabata H et al (2013) Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 111:841\u2013845","journal-title":"Am J Cardiol"},{"key":"1040_CR25","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"D Trenk","year":"2012","unstructured":"Trenk D, Stone GW, Gawaz M et al (2012) A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug eluting stents. J Am Coll Cardiol 59:2159\u20132164","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-013-1040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-013-1040-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-013-1040-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:02:04Z","timestamp":1559372524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-013-1040-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,22]]},"references-count":25,"alternative-id":["1040"],"URL":"https:\/\/doi.org\/10.1007\/s11239-013-1040-7","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,22]]}}}